US, Canada Continue to Push for Regulatory Harmonization in the Life Sciences And for the life science industry, increased cooperation means fewer regulatory barriers as well. In a July 2012 statement, the US and Canada ...
| ||||||||
Suven Life Sciences granted patents for neurodegenerative drug NEW DELHI: Pharmaceutical firm Suven Life Scienceshas been granted three product patents -- one each by South Korea, China and Canada -- for ...
| ||||||||
| Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business Integra LifeSciences Holdings Corporation IART, -0.64% today announced that it has made changes to the leadership of its Orthopedics and Tissue ...
| ||||||||
| Suven Life Sci - Suven Life Sciences secures (3) Product Patents for their NCEs in South Korea ... Suven Life Sciences Ltd has informed BSE regarding a Press Release datedSeptember 03, 2014, titled "Suven Life Sciences secures (3) Product ...
| ||||||||
Scotland-based life scientists issue independence warning The academics are led by Margaret Frame, science director at Cancer ... the University of Glasgow's College of Medical, Veterinary and Life Sciences, ...
| ||||||||
| Biocrates Life Sciences launches metabolomics-based bile acids kit Biocrates Life Sciences, a developer of cutting-edge mass-spectrometry-based kit products, announces the launch of the first-ever bile acids kit based ...
| ||||||||
Integra Lifesciences Expresses Interest to Divest Spine Business Last week, Glenn Coleman the CFO of IntegraLifesciences, expressed to analysts that the company is interested in exploring strategic alternatives for ...
| ||||||||
| BIOCRATES Life Sciences introduces standardized metabolomics-based bile acids kit BIOCRATES Life Sciences AG, developer of cutting-edge mass-spectrometry-based kit products, has launched the first-ever bile acids kit based on ... BIOCRATES Life Sciences GmbH Announces Launch Of First ever Standardized Metabolomics ... - BioSpace
| ||||||||
| Momentum Stocks in Focus -Regeneron Pharmaceuticals Inc(NASDAQ:REGN),Edwards ... Edwards Lifesciences Corp(NYSE:EW) provides products and technologies to treat structural heart disease and critically ill patients worldwide.
|
Wednesday, September 3, 2014
Life Sciences
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment